4107 — ISE Chemicals Balance Sheet
0.000.00%
- ¥93bn
- ¥85bn
- ¥26bn
- 90
- 30
- 61
- 68
Annual balance sheet for ISE Chemicals, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,590 | 3,134 | 6,276 | 8,387 | 9,720 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12,087 | 10,789 | 8,048 | 6,149 | 6,691 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 18,138 | 17,809 | 18,360 | 20,413 | 24,141 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,861 | 11,931 | 13,910 | 14,485 | 14,702 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 30,353 | 31,069 | 33,415 | 36,146 | 40,082 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,988 | 3,811 | 4,615 | 5,215 | 6,806 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,638 | 5,389 | 6,285 | 6,926 | 8,190 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 24,715 | 25,680 | 27,130 | 29,220 | 31,892 |
Total Liabilities & Shareholders' Equity | 30,353 | 31,069 | 33,415 | 36,146 | 40,082 |
Total Common Shares Outstanding |